Thyrocytes normally express major histocompatibility complex (MHC) class I, but not class U, cell surface antigens. A rat thyrocyte cell line, FRTL-5, also expresses MHC class I antigens, in addition to a variety of thyroid-specific genes. Treatment of FRTL-5 thyrocytes with physiological concentrations of thyroid-stimulating hormone (TSH) has been shown to induce increased expressed of thyroglobulin and thyroid peroxidase but to simultaneously decrease expression of the TSH receptor. The reduction in TSH receptor expression by TSH is cAMP mediated. In the present study, it is demonstrated that, in thyrocytes treated with TSH, MHC class I expression decreases concomitant with the decrease in TSH receptor expression. This decreased expression is evidenced by reduced cell surface levels of MHC class I antigens, by reduced steady-state RNA levels, and by reduced transcription of the class I genes. TSH-mediated reduction of MHC class I gene transcription in FRTL-5 cells was mapped to a region within 135 base pairs of the promoter.
Many of the human thyroid diseases, including Graves and Hashimoto, appear to be autoimmune diseases. As a result, the roles of the major histocompatibility (MHC) class I and class II cell surface molecules in the etiology ofthese diseases have been examined extensively (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Both class I and class II molecules are glycoproteins that play pivotal roles in the induction and propagation of immune responses (11) (12) (13) . The MHC class I molecules function primarily as the targets of the cellular immune response, whereas the class II molecules regulate both the humoral and cellular immune responses. In Graves disease and autoimmune thyroiditis, both class I and class II cell surface levels have been shown to be elevated. Although there have been extensive studies on the factors regulating class II expression in thyrocytes, including the rat FRTL-5 thyroid cell model (5) (6) (7) (8) (9) (10) , less attention has been focused on the patterns of expression of MHC class I molecules.
Thyroid-stimulating hormone (TSH) has pleiotropic effects on thyrocytes: induction of thyroglobulin (Tg) and thyroid peroxidase (TPO) mRNA and protein, increased iodide uptake, and generation and secretion of the thyroid hormones T3 and T4 (14) . TSH also regulates TSH receptor (TSHr) gene transcription, but by a complex process. Thus, in the functioning rat FRTL-5 cell, TSH induces an initial transient increase in TSHr RNA levels followed by a significant reduction in TSHr gene transcription concomitant with its stimulation ofTg, TPO, and iodide uptake (15) (16) (17) . The TSHr response to TSH, like those of Tg and TPO, has been demonstrated to be mediated primarily by cAMP (16, 17) .
In the present study, we have investigated TSH regulation of expression of MHC class I genes in thyrocytes and report that class I genes are expressed in these cells and that expression is reduced by TSH. The TSH-induced decrease in expression is dependent on the presence of the TSHr, is cAMP-mediated, and is transcriptional. TSH-mediated reduction of class I transcription is mapped to a region of 135 base pairs (bp) upstream of the promoter, which contains a DNA sequence element homologous to a cAMP response element (CRE). (14) (15) (16) (17) (18) and were grown as described (18) in Coon's modified F12 medium supplemented with 5% calf serum, 1 mM nonessential amino acids (GIBCO), and a mixture of six hormones including TSH (0.1 nM). Cells were diploid, between their 5th and 25th passage, and were passaged every 7-10 days. They were provided fresh medium every 2 or 3 days, and, as appropriate to individual experiments, cells were transferred to medium without TSH for 6 days before use. FRT rat thyroid cells, although derived from early, parental FRTL cell cultures (19) , have no functional TSHr and no TSHr RNA (15) . They are maintained in Coon's modified F12 medium containing 5% serum (19) . The fulllength TSHr (T8AFB) cDNA was subcloned into the simian virus 40 (SV40) promoter-driven pSG5 vector and introduced into FRT thyroid cells by electroporation as described (15, 16) . Subclones were screened for their ability to bind 125I-labeled TSH (16) ; the subclone used in this report, T28, exhibited specific TSH binding and TSH-increased cAMP levels as described for subclone T33 (16) .
MATERIALS AND METHODS
RNA Isolation and Analysis. Total cellular RNA and poly(A)+ RNA were isolated by standard procedures (15, 16, 20, 21) . Northern blot analyses were performed as described (15, 16) ; final washes were carried out at 65°C in lx SSPE (150 mM NaCI/10 mM NaH2PO4/1 mM EDTA, pH 7.4). The rat TSHr probe was the purified insert fragment of clone T8AFB, spanning residues -54 to 2780 of the reported nucleotide sequence of the rat TSHr gene (15, 16 class I probe was the 1.0-kilobase Hpa II fragment of the pH7 clone (22) , which spans the entire cDNA insert. The rat Tg probe was the 3' insert used previously (23) . Rat /-actin was kindly provided by B. Paterson (National Cancer Institute). All probes were radiolabeled by either random priming (24) or nick-translation (25) .
Transcription Extension Assays. In vitro transcription extension (run-on) assays were performed as described (17, 26) . Briefly, nuclei, isolated from 2 x 108 cells in the presence of 0.5% Nonidet P-40, were washed and suspended in 1 ml of buffer containing 50 mM Tris (pH 8.0), 140 mM KCI, 10 mM MgCl2, 0.5 mM GTP, 0.5 mM ATP, 0.5 mM CTP, 250 tkCi of
[32P]UTP, 1 mM dithiothreitol, and RNasin (200 units/ml).
The mixture was incubated for 30 min at 370C. Radiolabeled RNA was isolated and used to measure specific mRNA transcription by filter hybridization with the TSHr, class I, thyroglobulin, and ,3-actin cDNA inserts or control (pSG5 or pUC19) plasmid DNA immobilized on 0.45-,um Nytran membranes.
Transfection of FRTL-5 Cells. FRTL-5 cells were grown to 60-70%o confluency in 6H medium and then shifted to medium without TSH, insulin, or hydrocortisone for 1 day. Six hours before transfection, the medium was changed. Cells were then transfected by the DEAE-dextran method with 10 ,Ag of DNA (27) . After 18 hr, the medium was again changed, and the cells were incubated with or without TSH for an additional 48 hr. The transfected DNA samples were either pSV2, containing an SV40 promoter linked to the chloramphenicol acetyltransferase (CAT) gene (28) . CAT assays were as described and used 10-20 ,ug of lysate (28) .
Fluorescence-Activated Cell Sorter Analysis. Single-cell suspensions were prepared and stained as described (29) . Directly fluoresceinated monoclonal antibody against the rat MHC class I antigen was RT1A (Serotec; no. MCA 51F), which reacts with a monomorphic class I determinant. A directly fluoresceinated monoclonal antibody, Leu-4 (Becton Dickinson), was used as a background control.
Statistical Significance. Significance between experimental values was determined using the Student t test when only two groups existed. Differences between and within groups were also evaluated by two-way analysis of variance. Values were considered significant ifP < 0.05. In all cases n represents the number of experiments using different batches of cells and performed on different days.
RESULTS
TSH Reduces MHC Class I Expression in FRTL-5 Cells. Treatment of the rat thyrocyte line FRTL-5 with TSH has been shown to trigger a variety of molecular responses. Among these are increased Tg synthesis, iodide transport, and TPO activity (see below and ref. 14) . Concomitant with these observed increases, TSH causes a net decrease in cell surface levels of TSHr protein and RNA levels (see below and refs. [15] [16] [17] . The effect of TSH on MHC class I RNA in thyrocytes was examined by Northern blot analysis of total RNA (Table 1) . After TSH treatment for 24 hr, steady-state MHC class I RNA levels were reduced to less than one-half the levels in untreated cells. The decrease was dependent on the TSH concentration; thus, levels were 77% ± 12% of control values at 0.01 nM TSH, 41% ± 4% at 0.1 nM TSH (Table 1) , and 29% ± 12% at 1 nM TSH.
The kinetics of the class I RNA response to TSH was measured over a period of 24 hr of treatment ( Fig. 1) . A sharp decrease in steady-state levels of class I RNA occurred within 1 hr of TSH treatment, followed by a more gradual Quantitation was by densitometry of class I-specific and TSHrspecific RNA following hybridization with the appropriate probe. The ratio is the ratio of RNA levels in TSH-treated relative to untreated samples.
decline, which was maximal between 8 and 24 hr after treatment (Fig. 1 ). This maximal decrease was still measurable after 48 hr (data not shown). In contrast, in untreated controls, the level of class I RNA remained constant over the 24 hr of treatment.
To distinguish whether this decrease in steady-state RNA levels was due to decreased transcription or to increased stability of class I RNA, the transcription rate of MHC class I RNA was assessed in TSH-treated and untreated FRTL-5 cells (Fig. 2) . Whereas the rate of Tg RNA synthesis increased -5-to 10-fold following TSH treatment, the rate of class I RNA synthesis decreased to 33% + 6% of the control rate. This decreased rate of synthesis paralleled the decrease in steady-state class I RNA levels. The rate of TSHr RNA synthesis declined to 42% + 8% of its control rate, the same degree as observed for class I synthesis. Fig. 1 , the relative amount of radiolabeled class I, TSHr, or Tg pre-mRNA from cells never exposed to TSH was set to one, and the values for data from TSH-treated cells were compared.
cAMP Reduces Class I RNA Levels in FRTL-5 Cells. TSH binding to the TSHr is known to increase intracellular levels of both Ca2' and cAMP (14) (15) (16) (17) . The observed decrease in TSHr RNA following TSH treatment of FRTL-5 cells is mediated by cAMP. To determine whether either of these agents could mediate the TSH-triggered reduction of class I expression, the effects of both Ca2+ ionophores and cAMP on class I expression were examined. Treatment of FRTL-5 cells with the ionophore ionomycin did not result in a decrease in class I RNA levels (Table 2 ). However, decreases in class I RNA levels were observed after treatment of FRTL-5 cells with 8-Br-cAMP and with either forskolin or cholera toxin ( Table 2) , both of which cause increased intracellular cAMP levels (14) (15) (16) (17) . In all three treatment conditions, the magnitude of the reduction approximated that observed with TSH treatment (Table 1 (15, 16, 19) . The effect of TSH on class I RNA levels was examined in FRT cells (Fig. 3A) . Unlike FRTL-5 cells, which expressed less class I RNA in response to TSH treatment, the Cholera toxin (10 ng/ml), forskolin (10 MM), ionomycin (1 AM), and phorbol 12-myristate 13-acetate (20 nM) were added to the medium of cells exposed for 6 days to 5H medium with no TSH as in Fig. 1 and Table 1 . RNA was isolated 24 hr later. By using the same blots, it was shown that TSHr/,3-actin ratios were decreased by >50%o by cholera toxin, forskolin, and ionomycin as reported (15) (16) (17) (16) . Cells were maintained 6 days in 5H medium (no TSH) as in Fig. 1 (Fig. SA) . In addition, a DNA sequence element homologous to a CRE occurs within 135 bp of initiation of transcription (Fig. 5 A and B) . To 
DISCUSSION
The physiological role of TSH is to stimulate the production of a variety of thyroid products necessary for the synthesis and release of the hormones T3 and T4 (i.e., Tg and TPO). This process has been well documented in rat FRTL-5 cells as well as human thyroid cells (14) . In rat FRTL-5 cells, TSH effects on TSHr expression are complex, but result in a net decrease in TSHr RNA levels, presumably as a negative feedback mechanism that may be part of the desensitization process (15) (16) (17) . In the present study, we demonstrate that TSH treatment of FRTL-5 cells also reduces expression of MHC class I genes, whose products are not directly involved in the functional homeostasis of the cell.
TSH mediates the reduction in steady-state levels and transcription of MHC class I genes in the rat thyrocyte line FRTL-5. After TSH treatment, a rapid decline in the steadystate level of class I RNA is followed by a more gradual fall, which is maximal at 24 hr. The overall decline in steady-state levels of class I RNA can be accounted for by the decreased rate of synthesis. The TSH effect is mediated through the TSHr, since cell lines that do not express the TSHr do not reduce class I levels in response to TSH. The major physiological effect of TSH on thyrocytes is to increase intracel- Proc. Natl. Acad. Sci. USA 89 (1992) lular cAMP levels. Directly increasing intracellular cAMP levels, by either forskolin, cholera toxin, or 8-Br-cAMP, also results in reduction in class I RNA levels, suggesting that the TSH effect on class I is mediated by cAMP. In contrast, calcium ionophores and phorbol esters have no effect on class I expression.
The DNA sequence responsible for the TSH response of the class I gene mapped to a region of 135 bp containing the class I promoter and 5' flanking sequences. Contained within this DNA segment is a DNA sequence element, TGACG-CGA, with homology to the CRE, TGACGTCA (Fig. 5B) . To our knowledge, this class I element has not been previously described and represents an additional functional element. Previous studies reported that cAMP increases expression of a class I promoter in transient transfection of HeLa cells and mapped the response element to the constitutive enhancer region (CIR/A; Fig. 5A ) (30) . The reasons for the discrepancy between the present study and the earlier one are not clear. It cannot be due simply to differences in the cell type, since we have observed that a variety of cells decrease endogenous class I expression in response to cAMP (J.M., L.D.K., and D.S.S., unpublished results). It is possible that the differences may reflect differences in the promoter itself. In the earlier study, the enhancer region was attached to a heterologous promoter, possibly altering the normal context ofthe element and therefore its response. In the present study, the enhancer region remains associated with its homologous promoter.
The changes in transcription and steady-state levels of RNA triggered by TSH and cAMP are reflected in changes in cell surface expression of class I molecules. After treatment with either TSH or forskolin, cell surface expression of MHC class I molecules is reduced -2-fold. Although surface levels of class I in thyrocytes are normally low relative to lymphoid cells, TSH specifically triggers a further reduction in this level. The ability of TSH to decrease MHC class I gene and antigen expression is very different from its effect on class II gene and antigen expression in FRTL-5 cells (8) . Thus, TSH alone has no effect on class II but is necessary for interferonmediated increases in class II gene expression. The basis for this difference in regulation is not clear.
Because all of the other known actions of TSH are related to its role in thyroid function or growth, it is tempting to speculate that these changes could have functional consequences in vivo. In studies to be published elsewhere, we show that insulin, insulin-like growth factor 1, and hydrocortisone can also negatively regulate class I expression (31) . We suggest that hormonal signals induce a reduction in class I expression that may be necessary to avoid immune responses to thyroid products (i.e., TPO and Tg), which are known autoantigens present in the sera of patients with autoimmune thyroid disease (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Continued examination of hormonal regulation of MHC class I expression in FRTL-5 cells should provide additional information concerning regulatory elements of MHC class I genes as well as serve as a model to better understand the development or progression of autoimmune Graves disease.
